The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
X-ray crystal structure analysis of elacestrant (RAD1901), a novel selective estrogen receptor degrader (SERD), bound to estrogen receptor alpha ligand binding domain.
 
Sean W. Fanning
Consulting or Advisory Role - ExpertConnect; Guidepoint Inc
Other Relationship - StructureGen
 
Geoffrey Greene
Leadership - Olema Pharmaceuticals
Stock and Other Ownership Interests - Olema Pharmaceuticals
Consulting or Advisory Role - Eisai; Sermonix Pharmaceuticals
Research Funding - Sermonix Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Active Motif; Biolegend; Life Technologies; Santa Cruz Biotechnology
Travel, Accommodations, Expenses - Eisai
Other Relationship - Boost Therapeutics; StructureGen
 
Maureen G. Conlan
Employment - Radius Health
Stock and Other Ownership Interests - Radius Health